Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil and Hydromorphone PCA for Spinal Neoplasm Surgery
NCT04111328Phase 4Completed
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sufentanil, hydromorphone in postoperative pain. Started Oct 2019; status: completed.
02
Drugs
sufentanilhydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04111328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111328.